Literature DB >> 1647924

Early loss of neurogenic inflammation in the human diabetic foot.

D Walmsley1, P G Wiles.   

Abstract

1. Neurogenic inflammation, mediated by nociceptor C fibres, is part of the acute neurovascular response to injury producing the axon reflex flare. Laser Doppler flowmetry was used to measure the flare response induced by the electrophoresis, at various current strengths, of a ring of acetylcholine solution into dorsal foot skin. 2. Nineteen control subjects and 52 long-duration insulin-dependent (Type 1) diabetic patients of similar age (20 without complications; 19 with laser-treated retinopathy; 13 with reduced vibration perception and retinopathy) were studied in order to investigate the possible attenuation of this defence mechanism in diabetes. 3. The maximal (1 mA) flare response [control median (interquartile range): 1.55 (1.16-2.06) arbitrary units] was reduced greatly in neuropathic patients [0.37 (0.24-0.66) arbitrary units; P less than or equal to 0.001 with respect to all other groups], especially those with a previous history of foot ulceration. The flare was also reduced in some patients with retinopathy alone [1.06 (0.56-1.27) arbitrary units; P less than 0.005 with respect to control subjects]. 4. No rightward shift of the curve of hyperaemic response plotted against current strength was found, suggesting that the abnormal response was due to axonal loss rather than to dysfunction. 5. Neurogenic inflammation, mediated by small pain fibres, was markedly impaired in a group of diabetic patients at risk of foot ulceration. Furthermore, impairment of this nociceptor C fibre response can develop before clinical large-fibre neuropathy and could itself predispose to foot complications.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1647924     DOI: 10.1042/cs0800605

Source DB:  PubMed          Journal:  Clin Sci (Lond)        ISSN: 0143-5221            Impact factor:   6.124


  7 in total

1.  Small fibre dysfunction, microvascular complications and glycaemic control in type 1 diabetes: a case-control study.

Authors:  P R J Vas; A Q Green; G Rayman
Journal:  Diabetologia       Date:  2011-12-23       Impact factor: 10.122

2.  Biological activity of C-peptide on the skin microcirculation in patients with insulin-dependent diabetes mellitus.

Authors:  T Forst; T Kunt; T Pohlmann; K Goitom; M Engelbach; J Beyer; A Pfützner
Journal:  J Clin Invest       Date:  1998-05-15       Impact factor: 14.808

Review 3.  Nociception at the diabetic foot, an uncharted territory.

Authors:  Ernst A Chantelau
Journal:  World J Diabetes       Date:  2015-04-15

Review 4.  Diabetic foot ulcers. Pathophysiology, assessment, and therapy.

Authors:  C K Bowering
Journal:  Can Fam Physician       Date:  2001-05       Impact factor: 3.275

Review 5.  Diabetic neuropathy and microcirculation.

Authors:  Chantel Hile; Aristidis Veves
Journal:  Curr Diab Rep       Date:  2003-12       Impact factor: 5.430

6.  Regional differences in cell-mediated immunity in people with diabetic peripheral neuropathy.

Authors:  K Pickwell; M Geerts; D van Moorsel; D Hilkman; M Kars; N C Schaper
Journal:  Diabet Med       Date:  2019-10-10       Impact factor: 4.359

7.  Vasomodulation of peripheral blood flow by focused ultrasound potentiates improvement of diabetic neuropathy.

Authors:  Joo-Shin Tan; Chou-Ching Lin; Gin-Shin Chen
Journal:  BMJ Open Diabetes Res Care       Date:  2020-03
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.